Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Dermatomycoses Market From 2025 To 2029?

The market for dermatomycoses has seen a consistent growth over the past years. The market is projected to expand from $14.12 billion in 2024 to $14.81 billion in 2025, with a compound annual growth rate (CAGR) of 4.9%. The historic growth of the market has been driven by several factors, including advancements in antifungal treatments, an increased prevalence of fungal infections, heightened understanding of skincare, improved diagnostic methods, and the growth of over-the-counter antifungal merchandise.

Anticipations indicate a robust expansion in the dermatomycoses market size in the coming years, projecting it to reach $18.17 billion by 2029, with a 5.3% Compound Annual Growth Rate (CAGR). This anticipated growth in the upcoming years can be ascribed to factors such as the enlarging elderly population, the escalating occurrence of drug-resistant fungus types, a soaring demand for organic and natural antifungal items, progress in biotechnology and research on antifungal agents, and the growth of healthcare availability in underdeveloped areas. The forecast period is set to observe key trends like the creation of new antifungal medications, progress in fast diagnostic methods, the application of artificial intelligence in dermatology, advancements in nanotechnology for antifungal treatments, and new developments in microbiome-based treatments.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21934&type=smp

What Are the Core Market Drivers Propelling Growth in the Dermatomycoses Industry?

The dermatomycoses market’s anticipated growth is largely influenced by the escalating occurrence of fungal infections. These are conditions brought on by fungi, leading to health complications upon infection of numerous areas such as the skin, hair, nails, or internal organs. The overly frequent usage of broad-spectrum antibiotics disrupts the natural microbiome, providing a conducive environment for fungi to flourish and induce infections. Such an imbalance compromises the body’s inherent protective mechanisms, leaving one more susceptible to potential fungal infections. Dermatomycoses, resulting from dermatophytes, yeasts, and molds, contribute towards a variety of superficial and systematic infections, affecting different tissues. To illustrate, the UK Health Security Agency reported in November 2023 that global estimates show an annual incident rate of 6.5 million invasive fungal infections. This led to an estimated 3.8 million deaths, with 2.5 million directly linked to these infections. Consequently, the dermatomycoses market is stimulated by the rising prevalence of fungal infections.

How Is the Dermatomycoses Market Segmented?

The dermatomycosesmarket covered in this report is segmented –

1) By Drugs: Corticosteroids; Corticosteroid-Sparing Agents; Immunosuppressive; Immunomodulator; Antifungals; Other Drugs

2) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration

3) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids

2) By Corticosteroid-Sparing Agents: Tacrolimus; Pimecrolimus

3) By Immunosuppressive: Methotrexate; Azathioprine; Cyclophosphamide

4) By Immunomodulator: Interferon-Gamma; Thalidomide

5) By Antifungals: Topical Antifungals; Oral Antifungals; Systemic Antifungals

6) By Other Drugs: Antihistamines; Antibacterial Agents

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21934&type=smp

Which Regions Are Driving the Next Phase of the Dermatomycoses Market Growth?

North America was the largest region in the dermatomycoses market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatomycoses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Dermatomycoses Industry?

Key players in the dermatomycoses sector are directing their attention to developing investigational new drugs (INDs) as a means of enhancing efficiency in onychomycosis treatment. INDs are pharmaceutical compounds still undergoing either preclinical or clinical trials, all in a bid to assess their safety, efficacy, and paths to regulatory approval before they are officially marked as approved treatments. For example, in January 2024, Vanda Pharmaceuticals, Inc., which operates from the United States, was approved for an Investigational New Drug, VTR-297 by the US Food and Drug Administration (FDA) for onychomycosis treatment. VTR-297 is seen as a promising antifungal candidate due to its Histone Deacetylase (HDAC) inhibitory characteristics. This sets it apart from conventional antifungal treatments as it addresses the issue at its foundation—fungal growth. The drug has shown powerful antifungal activity against dermatophytes and other related fungi. This novel mode of action could potentially offer quicker and more effective treatment outcomes while also diminishing the chances of re-infection, thereby fulfilling a considerable need in onychomycosis treatment.

View the full report here:

https://www.thebusinessresearchcompany.com/report/dermatomycoses-global-market-report

How Is the Dermatomycoses Market Defined and What Are Its Core Parameters?

Dermatomycoses are a group of fungal infections affecting the skin, hair, and nails, primarily caused by dermatophytes, yeasts, or molds. These infections often lead to itching, scaling, redness, and skin inflammation, impacting overall skin health. The main goal of treatment is to eliminate the fungal infection, alleviate symptoms, and prevent recurrence through the use of antifungal medications, maintaining proper hygiene, and following effective skin care practices.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21934

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model